FdaApplication

BLA 761398

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFresenius Kabi USA, LLC
application_typeBLA
approval_date2025-03-25

Products (3)

ProductActive ingredientStrengthDosage form
CONEXXENCEDENOSUMAB-BNHT60MG/MLInjection
BOMYNTRA—120MG/1.7ML (70MG/ML)Injection
BOMYNTRADENOSUMAB-BNHT120MG/1.7ML (70MG/ML)Injection

3 products